ÂÜÀòÂÒÂ×

Ipek Özer Stillman is an experienced professional in health economics and market access, currently serving as Head of Global Health Economics, Payer Value & Patient Access at Takeda. Previous roles include Head of Global Health Economics at Shire and Director of Global Health Economics, Outcomes Research & Epidemiology at the same organization. Ipek has also held senior positions at Evidera as Senior Director & Senior Research Scientist, and at United BioSource Corporation as Director of Health Economic Modeling & Simulation. Additionally, Ipek served as Director of Health Economics and Outcomes Research at Abt Bio-Pharma Solutions, a subsidiary of Abt Associates. Ipek is pursuing further education at MIT Sloan School of Management.